JPS596844B2 - 駆虫剤液体組成物 - Google Patents
駆虫剤液体組成物Info
- Publication number
- JPS596844B2 JPS596844B2 JP49069787A JP6978774A JPS596844B2 JP S596844 B2 JPS596844 B2 JP S596844B2 JP 49069787 A JP49069787 A JP 49069787A JP 6978774 A JP6978774 A JP 6978774A JP S596844 B2 JPS596844 B2 JP S596844B2
- Authority
- JP
- Japan
- Prior art keywords
- administration
- animals
- pour
- pouring
- animal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title claims description 33
- 230000000507 anthelmentic effect Effects 0.000 title claims description 9
- 239000007788 liquid Substances 0.000 title claims description 7
- 241001465754 Metazoa Species 0.000 claims description 36
- 239000004480 active ingredient Substances 0.000 claims description 12
- 239000003085 diluting agent Substances 0.000 claims description 7
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 4
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 claims description 4
- NNBZCPXTIHJBJL-UHFFFAOYSA-N decalin Chemical compound C1CCCC2CCCCC21 NNBZCPXTIHJBJL-UHFFFAOYSA-N 0.000 claims description 4
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims description 2
- DYYKAVHVTLJEOH-UHFFFAOYSA-N 6-phenylimidazo[2,1-b][1,3]thiazole Chemical compound N1=C2SC=CN2C=C1C1=CC=CC=C1 DYYKAVHVTLJEOH-UHFFFAOYSA-N 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- 229960002380 dibutyl phthalate Drugs 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 description 17
- 238000000034 method Methods 0.000 description 17
- 238000012360 testing method Methods 0.000 description 12
- 241000283690 Bos taurus Species 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 238000009472 formulation Methods 0.000 description 8
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 description 7
- 235000013601 eggs Nutrition 0.000 description 7
- 238000002347 injection Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- 229960001614 levamisole Drugs 0.000 description 7
- 229940079593 drug Drugs 0.000 description 6
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000002496 gastric effect Effects 0.000 description 5
- 241000243976 Haemonchus Species 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 229960001952 metrifonate Drugs 0.000 description 4
- 238000007911 parenteral administration Methods 0.000 description 4
- NFACJZMKEDPNKN-UHFFFAOYSA-N trichlorfon Chemical compound COP(=O)(OC)C(O)C(Cl)(Cl)Cl NFACJZMKEDPNKN-UHFFFAOYSA-N 0.000 description 4
- 241001126268 Cooperia Species 0.000 description 3
- 241000243789 Metastrongyloidea Species 0.000 description 3
- 241001494479 Pecora Species 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 229940124339 anthelmintic agent Drugs 0.000 description 3
- 239000000921 anthelmintic agent Substances 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 239000004540 pour-on Substances 0.000 description 3
- -1 rhphOn Chemical class 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 238000010254 subcutaneous injection Methods 0.000 description 3
- 239000007929 subcutaneous injection Substances 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 241000244206 Nematoda Species 0.000 description 2
- 241000510960 Oesophagostomum Species 0.000 description 2
- 241000935974 Paralichthys dentatus Species 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 239000002318 adhesion promoter Substances 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical class CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Polymers FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 241001465677 Ancylostomatoidea Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006500 Brucellosis Diseases 0.000 description 1
- 241000931178 Bunostomum Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- PNVJTZOFSHSLTO-UHFFFAOYSA-N Fenthion Chemical compound COP(=S)(OC)OC1=CC=C(SC)C(C)=C1 PNVJTZOFSHSLTO-UHFFFAOYSA-N 0.000 description 1
- 208000007212 Foot-and-Mouth Disease Diseases 0.000 description 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 238000011887 Necropsy Methods 0.000 description 1
- 241000243795 Ostertagia Species 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 241000276498 Pollachius virens Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000978776 Senegalia senegal Species 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 241001480236 Strongyloides ratti Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000242541 Trematoda Species 0.000 description 1
- 241000243797 Trichostrongylus Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- UGMCXQCYOVCMTB-UHFFFAOYSA-K dihydroxy(stearato)aluminium Chemical class CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O UGMCXQCYOVCMTB-UHFFFAOYSA-K 0.000 description 1
- KSDGSKVLUHKDAL-UHFFFAOYSA-L disodium;3-[2-carboxylatoethyl(dodecyl)amino]propanoate Chemical compound [Na+].[Na+].CCCCCCCCCCCCN(CCC([O-])=O)CCC([O-])=O KSDGSKVLUHKDAL-UHFFFAOYSA-L 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 208000009724 equine infectious anemia Diseases 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 230000001418 larval effect Effects 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000003254 palate Anatomy 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2331793A DE2331793B2 (de) | 1973-06-22 | 1973-06-22 | Anthelmintische Pour on-Formulierung |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5035342A JPS5035342A (en, 2012) | 1975-04-04 |
JPS596844B2 true JPS596844B2 (ja) | 1984-02-15 |
Family
ID=5884781
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP49069787A Expired JPS596844B2 (ja) | 1973-06-22 | 1974-06-20 | 駆虫剤液体組成物 |
Country Status (12)
Country | Link |
---|---|
US (1) | US3980791A (en, 2012) |
JP (1) | JPS596844B2 (en, 2012) |
BE (1) | BE816686A (en, 2012) |
BR (1) | BR7405115D0 (en, 2012) |
DE (1) | DE2331793B2 (en, 2012) |
FR (1) | FR2233985B1 (en, 2012) |
GB (1) | GB1425810A (en, 2012) |
IE (1) | IE39520B1 (en, 2012) |
LU (1) | LU70356A1 (en, 2012) |
NL (2) | NL180633B (en, 2012) |
SU (1) | SU724077A3 (en, 2012) |
ZA (1) | ZA744001B (en, 2012) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63162531U (en, 2012) * | 1987-04-11 | 1988-10-24 | ||
JPS63162530U (en, 2012) * | 1987-04-11 | 1988-10-24 | ||
JPS63193847U (en, 2012) * | 1987-06-02 | 1988-12-14 |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4336262A (en) * | 1973-02-23 | 1982-06-22 | Fisons Ltd. | Pour-on veterinary anthelmintic |
US4070476A (en) * | 1973-02-23 | 1978-01-24 | Fisons Incorporated | Topical anthelmintic compositions and methods of use |
DE2614841A1 (de) * | 1976-04-06 | 1977-10-20 | Bayer Ag | Neue pour-on-formulierungen von anthelmintika |
JPS52171145U (en, 2012) * | 1976-06-19 | 1977-12-26 | ||
US4147785A (en) * | 1977-03-18 | 1979-04-03 | Graham J. Dobbie | Method for the treatment of onchocerciasis |
US4150141A (en) * | 1977-06-28 | 1979-04-17 | Johnson & Johnson | Treatment for scabies |
US4096271A (en) * | 1977-08-03 | 1978-06-20 | American Cyanamid Company | Slow release injectable formulations of tetramisole and derivatives in benzyl benzoate |
FR2484256B1 (fr) * | 1979-06-29 | 1986-10-24 | Roussel Uclaf | Procede de lutte contre les parasites des animaux a sang chaud |
US4278684A (en) * | 1980-06-17 | 1981-07-14 | Janssen Pharmaceutica N.V. | Non-toxic anthelminthic pour-on composition |
DE3029426A1 (de) * | 1980-08-02 | 1982-03-11 | Bayer Ag, 5090 Leverkusen | Gegen zwecken wirksame pour-on-formulierungen |
US4287176A (en) * | 1980-10-09 | 1981-09-01 | American Cyanamid Co. | Anthelmintic levamisole and tetramisole gel compositions |
GB2095107A (en) * | 1981-03-24 | 1982-09-29 | Janssen Pharmaceutica Nv | Tetramisole-or levamisole pour-on compositions |
US4607050A (en) * | 1981-10-19 | 1986-08-19 | Wellcome Australia Limited | Method of controlling insects and parasites with an aqueous localized pour-on formulation |
NZ202526A (en) * | 1981-11-27 | 1985-10-11 | Ici Australia Ltd | Endoparasiticidal(pour-on)compositions containing tetramisole |
ATE42196T1 (de) * | 1982-12-13 | 1989-05-15 | American Cyanamid Co | Athelminthische gele und verfahren zu deren herstellung bei raumtemperatur. |
AU2314184A (en) * | 1983-01-10 | 1984-07-12 | Robert Young & Company Limited | Endoparasiticidal composition containing levamisole |
GB8304927D0 (en) * | 1983-02-22 | 1983-03-23 | Wellcome Found | Pesticidal formulations |
NZ209100A (en) * | 1983-08-22 | 1987-01-23 | Ici Australia Ltd | Topical compositions for control of endoparasites |
EP0147883A3 (en) * | 1983-12-21 | 1986-12-30 | Janssen Pharmaceutica N.V. | Aqueous non-aggressive anthelmintic pour-on formulations |
WO1993015716A1 (en) * | 1992-02-11 | 1993-08-19 | Janssen Pharmaceutica N.V. | Levamisole or tetramisole based pour-on formulations |
JP2855181B2 (ja) | 1993-12-10 | 1999-02-10 | 敏雄 鈴木 | 松類の枯損防止用組成物及び防止方法 |
DE4443888A1 (de) * | 1994-12-09 | 1996-06-13 | Bayer Ag | Dermal applizierbare Formulierungen von Parasitiziden |
WO2000074489A1 (en) * | 1999-06-04 | 2000-12-14 | Nufarm Limited | Stable biocidal compositions |
GB0501220D0 (en) * | 2005-01-21 | 2005-03-02 | Norbrook Lab Ltd | Anthelmintic composition |
US9901092B2 (en) | 2006-09-12 | 2018-02-27 | Nippon Soda Co., Ltd. | Pest control agent in form of stable suspension |
RU2440109C2 (ru) * | 2010-03-31 | 2012-01-20 | Государственное научное учреждение (ГНУ) Всероссийский научно-исследовательский институт гельминтологии им. К.И. Скрябина (ВИГИС) | Способ лечения описторхоза плотоядных животных |
US20130230929A1 (en) * | 2010-06-29 | 2013-09-05 | National Institute Of Advanced Industrial Science And Technology | Agent for detecting halide, method for detecting halide, and detection sensor |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3642809A (en) * | 1965-10-05 | 1972-02-15 | American Cyanamid Co | Method for producing 2 3 5 6-tetra hydroimidazo-(2 1-b)thiazoles |
-
0
- NL NLAANVRAGE7408296,A patent/NL180633C/xx active
-
1973
- 1973-06-22 DE DE2331793A patent/DE2331793B2/de active Granted
-
1974
- 1974-06-19 LU LU70356A patent/LU70356A1/xx unknown
- 1974-06-20 NL NLAANVRAGE7408296,A patent/NL180633B/xx not_active IP Right Cessation
- 1974-06-20 JP JP49069787A patent/JPS596844B2/ja not_active Expired
- 1974-06-21 ZA ZA00744001A patent/ZA744001B/xx unknown
- 1974-06-21 FR FR7421706A patent/FR2233985B1/fr not_active Expired
- 1974-06-21 BE BE145728A patent/BE816686A/xx not_active IP Right Cessation
- 1974-06-21 SU SU742046507A patent/SU724077A3/ru active
- 1974-06-21 BR BR5115/74A patent/BR7405115D0/pt unknown
- 1974-06-21 IE IE1299/74A patent/IE39520B1/xx unknown
- 1974-06-24 GB GB2790574A patent/GB1425810A/en not_active Expired
- 1974-12-13 US US05/532,595 patent/US3980791A/en not_active Expired - Lifetime
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63162531U (en, 2012) * | 1987-04-11 | 1988-10-24 | ||
JPS63162530U (en, 2012) * | 1987-04-11 | 1988-10-24 | ||
JPS63193847U (en, 2012) * | 1987-06-02 | 1988-12-14 |
Also Published As
Publication number | Publication date |
---|---|
FR2233985B1 (en, 2012) | 1978-12-22 |
AU6988474A (en) | 1975-12-11 |
DE2331793B2 (de) | 1979-09-27 |
BR7405115D0 (pt) | 1975-01-07 |
FR2233985A1 (en, 2012) | 1975-01-17 |
IE39520B1 (en) | 1978-10-25 |
DE2331793A1 (de) | 1975-01-16 |
DE2331793C3 (en, 2012) | 1980-07-03 |
SU724077A3 (ru) | 1980-03-25 |
BE816686A (fr) | 1974-12-23 |
IE39520L (en) | 1974-12-22 |
NL7408296A (en, 2012) | 1974-12-24 |
GB1425810A (en) | 1976-02-18 |
JPS5035342A (en, 2012) | 1975-04-04 |
LU70356A1 (en, 2012) | 1975-03-27 |
ZA744001B (en) | 1975-07-30 |
US3980791A (en) | 1976-09-14 |
NL180633C (nl) | 1900-01-01 |
NL180633B (nl) | 1986-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS596844B2 (ja) | 駆虫剤液体組成物 | |
US4323582A (en) | Method of treating animals and humans for internal and external parasites | |
EP1119256B1 (en) | Oral combination of lufenuron and nitenpyram against fleas | |
HUP0104235A2 (hu) | Parazitaellenes készítmények | |
FI118788B (fi) | Loisten häätöön tarkoitettu koostumus | |
JP2010535231A (ja) | 内部寄生虫駆除局所組成物 | |
CA2364742C (en) | Anthelmintic composition | |
US5935591A (en) | Method for treatment of equine protozoal myeloencephalitis with thiazolides | |
TW200423871A (en) | Topical parasiticide formulations and methods of treatment | |
BG107038A (bg) | Гелен паразитициден състав | |
KR100236586B1 (ko) | 가축에서 벼룩을 방제하기 위한 1-(n-(할로-3-피리딜메틸))-n-메틸아미노-1-알킬아미노-2-니트로에틸렌 유도체 | |
Arther et al. | lmidacloprid plus moxidectin topical solution for the prevention of heartworm disease (Dirofiloria immitis) in dogs | |
KR20010013139A (ko) | 구충제 조성물 | |
DK156196B (da) | Fremgangsmaade til fremstilling af et tetramisol eller lavamisol paahaeldningspraeparat | |
EP4076447B1 (en) | Parasite control in ruminants | |
CN1245058A (zh) | 一种兽用抗病毒组合物 | |
IL96387A (en) | Pour-on formulations containing antibiotics effective for the control of internal and external parasites of homothermic animals | |
CA2622713C (en) | Anthelmintic formulations | |
CA1112170A (en) | Tetramisole and levamisole pour-on compositions and methods of use | |
Beesley | The effect of three organo‐phosphorus insecticides on certain arthropods which infest livestock | |
AU2004101082A4 (en) | Anthelmintic compositions | |
AU2004101084A4 (en) | Anthelmintic compositions | |
AU2005201107B2 (en) | Anthelmintic compositions | |
AU2008201426A1 (en) | Anthelmintic compositions | |
Taeniasis | T-Cells |